Classical, hormone driven signaling pathways that lead to post-translational phosphorylation of cell−cell adhesion components and alteration of their interaction kinetics play a major role in control endothelial barriers. Central to these cell−cell adhesions is the Vascular Endothelial cadherin (VE-cadherin), which binds to β-catenin (or plakoglobin) and through that to the actin-binding protein α-catenin. The stability of these interactions is strongly regulated by phosphorylation events occurring on all of these proteins. Signaling pathways induced by the Vascular Endothelial Growth Factor (VEGF) and other extracellular ligands regulate these phosphorylations and this is key to the control of endothelial permeability in inflammatory responses. The current understanding of VE-cadherins' phosphorylations, their importance in barrier control, and their regulating mechanisms is reviewed by Gavard L.

VEGF (and its relatives) is also a key regulator of vascular development and again regulation of (the stability of) VE-cadherin-dependent cell−cell adhesion is central. In their review, Lagendijk AK, et al. explain how the investigation of vascular development in zebrafish has revealed that regulators of cell−cell adhesion are among the major players involved. Furthermore, they highlight recent in vivo cell biology experiments in zebrafish embryos that have revealed details of vascular morphogenesis, in particular lumen formation, and that have illuminated the dymanics of cell−cell junctions during angiogenesis.

Besides hormone signaling and post-translational modification, cell−cell adhesion complexes in the vascular endothelium are also strongly controlled by mechanical forces within and organization of the actomyosin cytoskeleton that connects to them. These mechanical control mechanisms have received much attention over the last few years and they are the subject of three reviews in this issue. Van Buul JD, et al. provide a comprehensive review, based on database analyses and literature, of all the GEFs and GAPs expressed in the endothelium that regulate the Rho-family of small GTPases which are at the core of regulation the actomyosin cytoskeleton. Pannekoek WJ, et al. review recent literature about Rap1, which turns out to be an upstream regulator of Rho GTPase activity. Its specific role is to coordinate the location and timing of Rho and CDC42 activity. This controls contractility of radial and cortical actomyosin, respectively, and with that opening and closing of the endothelial barrier. Abu Taha A, et al. review recent literature that details the interaction between actomyosin and the VE-cadherin complex and show how actomyosin dynamics control junction integrity and stability at the microscopic level.

Thus, VE-cadherin-based endothelial cell−cell junction complexes are the integrators of multiple signals, both chemical and mechanical, that regulate the tightness and permeability of the vascular barrier. Receiving all these inputs they also make ideal sensors of vascular homeostasis. One way by which they may relay this information to adequate cellular response is by the control of a set of proteins that shuttle between cell−cell junctions and the nucleus. The most famous of these is the direct VE-cadherin interactor, and transcriptional co-factor β-catenin. Van den Berg MCW, et al. summarize the knowledge about these NACos (proteins that can localize to the nucleus and adhesion complexes) and highlight CCM1 as a relatively unknown member of this team that deserves our future attention.

Taken together, this collection provides a number of fun-to-read original reviews that span a large part of the current topics in vascular cell−cell adhesion. As such, it would be ideal to introduce relative lays to this field. At the same time, it also provides a detailed overview of these topics that will adequately refresh the mind of any expert. Finally, each of these reviews can be taken as an expert opinion on the directions this field may take to translate current knowledge into clinical application.
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![**Figure 1.** Johan de Rooij started his scientific career as a PhD student in the laboratory of Hans Bos at the University Medical Center Utrecht, where he studied Ras-like small GTPases. Among other Guanine Nucleotide Exchange Factors for the small GTPase Rap1, he identified Epac, the second known signaling target of the second messenger cyclic-AMP. During this educational period his interest was raised in the control mechanisms of epithelial cell adhesion. During his Post-Doc at Scripps, under the guidance of Clare Waterman and Martin Schwartz, this interest further developed as he found that feedback systems between integrins and actomyosin, controlling cellular mechanical forces ultimately defined the stability of cell--cell junctions and metastatic behavior of epithelial cells. This founded his current research, which he started at the Netherlands Cancer Institute, continued at the Hubrecht Institute and now pursues at the Center for Molecular Medicine at the University Medical Center Utrecht. Building on his labs' recent discoveries that the classical cadherin complex is a mechanosensor and that vinculin is an important effector in this that regulates adhesion stability, his lab now seeks to identify additional mechanosensitive molecules in the cadherin complex; understand the molecular details of these mechanotransducers; and perturb their regulation to elucidate their function in tissue morphogenesis and disease.](cam-8-98-g1){#F1}
